From: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
Clinicopathological features | AGBL2 expression (P; Spearman correlation) |
---|---|
Age | 0.076 (0.071) |
Tumor size | 0.053 (0.083) |
Clinical stage | 0.007 (0.157) |
Histological stage | 0.036 (0.121) |
Lymph node metastasis | 0.001 (0.184) |
Her2 status | 0.086 (0.036) |